All Articles

A major port expansion promises economic revival for the Baie Verte Peninsula, but at what cost to the environmental and community health of the region?

HCIactive's SmartBenefits.ai promises AI-powered clarity for your health plan, but a major data breach reveals the high-stakes risks of this new frontier.

Huntington Bank opens a South Euclid branch, blending community focus with an aggressive M&A strategy aiming to make it a top 10 U.S. bank.

Ripple just secured a federal bank charter for its stablecoin, RLUSD. This landmark move, enabled by the GENIUS Act, could redefine trust in crypto.

Updated trial results for Lilly's Inluriyo-Verzenio combo extend life without chemo, positioning the firm for dominance in a competitive oncology market.

Alamo Group's acquisition of Petersen Industries for $166.5M isn't just another deal. It's a strategic move to dominate the waste management equipment market.

A top Forbes ranking is impressive, but HealthWell Foundation's 100% fundraising efficiency reveals a new benchmark for non-profit impact. Here's how.

A top industrial firm offers a surprising blueprint for fixing healthcare's biggest challenges, from clinician burnout to supply chain woes.

Global crypto exchange HTX gains a crucial regulatory nod in Pakistan, paving the way for licensed operations in one of the world's fastest-growing digital asset hubs.

Amid a $2.37B buyout, Weiss Asset Management's increased stake in Avadel Pharma raises questions. Is it a vote of confidence or a strategic power play?

Greenway Technologies is leaving the lab. A new deal with a Native-owned firm aims to turn stranded gas into gold, but can the micro-plant economics work?

With FDA alignment for its pivotal Phase 3 trial, Oncolytics Biotech is poised to bring the first immunotherapy to the challenging pancreatic cancer landscape.

Hedge fund Balyasny Asset Management builds a 1.72% stake in JTC plc, signaling high-stakes maneuvering in the £2.3 billion takeover saga.

A routine filing by hedge fund Balyasny Asset Management may have just put Avadel Pharmaceuticals in the M&A spotlight. Here's what the signal means.

A new book arms working mothers with legal secrets HR won’t share, forcing businesses to rethink their strategic approach to talent and compliance.

Boston's Weiss Asset Management reveals a strategic 4.17% derivative stake in International Personal Finance as a takeover deadline looms.

This REIT's stock is worth millions, but it claims its apartments are worth much more. Can a bold strategic review unlock this hidden value for investors?

A deep dive into Perma-Pipe's record-breaking quarter, revealing a strategy of regional dominance and savvy diversification into high-growth tech sectors.

When a trusted professional evades over $1 million in taxes, the impact goes beyond the courtroom, shaking public trust and starving community services.

GrantWatch founder Libby Hikind is trading grant databases for picture books. Discover the strategy behind her pivot to value-driven children's literature.